Thema
Journal Article
58
Research Support, Non-U.S. Gov't
37
Clinical Trial, Phase II
18
Antineoplastic Agents
17
Ipilimumab
17
Multicenter Study
16
Research Support, N.I.H., Extramural
14
Antibodies, Monoclonal
13
Randomized Controlled Trial
13
Dacarbazine
12
Antibodies, Monoclonal, Humanized
10
Biomarkers, Tumor
10
Interleukin-2
10
7GR28W0FJI
9
Klinische Studie
9
Melanoma
9
Cisplatin
8
EC 2.7.11.1
8
Proto-Oncogene Proteins B-raf
8
Q20Q21Q62J
8
Research Support, U.S. Gov't, P.H.S.
8
5V9KLZ54CY
7
Clinical Trial, Phase III
7
DNA, Neoplasm
7
RNA, Messenger
7
Review
7
Vinblastine
7
Antigens, Neoplasm
6
BRAF protein, human
6
CTLA-4
6
Cancer Vaccines
6
Clinical Trial, Phase I
6
Comparative Study
6
DPT0O3T46P
6
Interferon-alpha
6
pembrolizumab
6
Paclitaxel
5
Vemurafenib
5
83869-56-1
4
Granulocyte-Macrophage Colony-Stimulating Factor
4
Immunotherapy
4
MAGEA3 protein, human
4
Neoplasm Proteins
4
Antigens, CD
3
BRAF inhibitor
3
CTLA-4 Antigen
3
CTLA4 protein, human
3
Canvaxin
3
EC 2.4.1.-
3
EC 2.7.10.1
3
mehr ...